Showing results (71-80 of 137) with videos related to

Sort By:
Pageof 14
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|January 24, 2022
Comparative study between sorafenib and lenvatinib as the first-line therapy in the sequential treatment of unresectable hepatocellular carcinoma in a real-world settingTaito Fukushima, Manabu Morimoto, Makoto Ueno, et al.
The Oncologist|April 6, 2023
Association Between Immune-Related Adverse Events and Survival in Patients with Hepatocellular Carcinoma Treated With Atezolizumab Plus BevacizumabTaito Fukushima, Manabu Morimoto, Satoshi Kobayashi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 4, 2024
Progression pattern and post-progression survival following atezolizumab and bevacizumab treatment in advanced hepatocellular carcinomaSatoshi Kobayashi, Taito Fukushima, Makoto Ueno, et al.
Digestive Diseases (Basel, Switzerland)|November 22, 2021
The Risk of Cirrhosis and Its Complications Based on PNPLA3 rs738409 G Allele FrequencyXue Shao, Haruki Uojima, Taeang Arai, et al.
Digestive Diseases (Basel, Switzerland)|August 8, 2020
Impact of Anti-GPIIb/IIIa Antibody-Producing B Cells as a Predictor of the Response to Lusutrombopag in Thrombocytopenic Patients with Liver DiseaseNaohisa Wada, Haruki Uojima, Takashi Satoh, et al.
European Journal of Gastroenterology & Hepatology|July 3, 2023
Impact of body composition for patients with hepatocellular carcinoma who received atezolizumab plus bevacizumab therapyHaruki Uojima, Makoto Chuma, Hisashi Hidaka, et al.
BMC Cancer|May 7, 2022
A prospective observational cohort study of lenvatinib as initial treatment in patients with BCLC-defined stage B hepatocellular carcinomaSatoshi Kobayashi, Taito Fukushima, Makoto Ueno, et al.
Digestive Diseases (Basel, Switzerland)|September 30, 2024
Esophageal Varices as an Independent Predictor of Fatal Outcomes after Balloon-Occluded Retrograde Transvenous Obliteration in Patients with Hepatic EncephalopathyShuichiro Iwasaki, Haruki Uojima, Shinya Sakita, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|May 9, 2022
Misunderstanding of hepatitis C virus (HCV) infection status by non-specialized medical doctors in patients who achieved sustained virologic response to anti-HCV therapyHidenori Toyoda, Satoshi Yasuda, Akio Moriya, et al.
International Journal of Clinical Oncology|June 27, 2026
Pretreatment serum vitamin D levels predict the therapeutic efficacy of atezolizumab plus bevacizumab therapy in advanced hepatocellular carcinoma: a multicenter analysisTakanori Suzuki, Kentaro Matsuura, Satoshi Narahara, et al.
Pageof 14